Target intelligence / Profile preview

Mab-21 domain-containing protein 2 (MB21D2)

Target
MB21D2
Molecular classification
Enzyme (putative nucleotidyltransferase, based on domain homology), Signaling protein (acts as scaffold/regulator), Other (cell fate-determining factor, molecular hub)
01

Overview

Mab-21 domain-containing protein 2 (MB21D2) is a member of the cGAS/DncV-like nucleotidyltransferase (CD-NTase) family and acts as a modulator of the cGAS-STING innate immune signaling pathway[1]. It physically interacts with and enhances cGAS activation, promoting liquid phase condensation, DNA binding, and cGAMP synthesis in response to DNA stimulation, leading to increased type I interferon production and antiviral/antitumor immunity[1]. MB21D2 is also implicated in cell fate determination, organogenesis, and cancer biology, particularly as a signaling hub connecting cadherin-binding, cell proliferation, migration, and epithelial-mesenchymal transition pathways; recurrent mutations (e.g., Q311E) and overexpression are found in head and neck squamous cell carcinoma, suggesting a role in cancer progression and stemness[2].

Other names
C3orf59hMB21D2D2ADANGER family member 2Anucleotidyltransferase MB21D2mab-21 domain-containing protein 2
02

Mechanism of action

Enhancement of cGAS enzymatic activity, leading to increased production of cyclic GMP-AMP (cGAMP), which activates interferon signaling. Possible scaffolding or adaptor function linking cadherin/E-cadherin and other signaling pathways.

03

Biological functions

Positive regulation of cGAS-STING signaling (innate immune sensor pathway)Facilitation of Type I interferon production (via enhancement of cGAS activity)Cell fate determination (including effects on organogenesis and development in metazoans)Cell proliferation, survival, and migration (implicated in cancer cell biology)Promotion of epithelial-mesenchymal transition and migratory phenotype in tumor cells
04

Disease associations

Cancer (frequent overexpression and mutation in head and neck squamous cell carcinoma)Antiviral immunity (modulation of response to DNA viruses)Immune response regulation
05

Safety considerations

Notable for roles in cell survival and proliferation; possible oncogenic potential if upregulated or mutated.Targeting MB21D2 could affect immune function and cell fate, raising concern for autoimmune or developmental effects unless targeted with specificity
06

Interacting drugs

None reported directly in the literature as of now; MB21D2 itself is not the known direct target of approved drugs, but potential therapeutic strategies may emerge from its role as a signaling hub
07

Biomarkers

Overexpression and presence of Q311E mutation in MB21D2 (especially in head and neck squamous cell carcinoma) could serve as a potential biomarker for aggressive tumor phenotypes

Beyond the preview

Go deeper on Mab-21 domain-containing protein 2 (MB21D2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mab-21 domain-containing protein 2 (MB21D2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call